Here we review the recent strategies for developing organic and inorganic molecular materials for application as electron and hole transport layers and as additives to achieve high efficiency and stability perovskite solar cells.
We report on the first systematic study of cobaloxime-based hydrogen photoproduction in mixed pH 7 aqueous/acetonitrile solutions and demonstrate that H2 evolution can be tuned through electronic modifications of the axial cobalt ligand or through introduction of TiO2 nanoparticles. The photocatalytic systems consist of various cobaloxime catalysts [Co(dmgH)2(L)Cl] (L = nitrogen-based axial ligands) and a water soluble porphyrin photosensitizer. They were assayed in the presence of triethanolamine as a sacrificial electron donor. Optimal turnover numbers related to the photosensitizer are obtained with electron-rich axial ligands such as imidazole derivatives (1131 TONs with N-methyl imidazole). Lower stabilities are observed with various pyridine axial ligands (443 TONs for para-methylpyridine), especially for those containing electron-acceptor substituents. Interestingly, when L is para-carboxylatopyridine the activity of the system is increased from 40 to 223 TONs in the presence of TiO2 nanoparticles.
A combination of noble-metal free components, a water soluble porphyrin photosensitizer zinc meso-tetrakis(1-methylpyridinium-4-yl)porphyrin chloride [ZnTMPyP(4+)]Cl4 (1) with cobaloxime complex [Co(III)(dmgH)2(py)Cl] (2) as a catalyst, creates an efficient system for photochemical hydrogen production acting under visible light with 280 TONs. This is the first example of a water soluble porphyrin acting as a photosensitizer for cobaloxime catalysed H2 production.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.